Effect of oral minoxidil with and without laser therapy in Male Pattern Hair Loss

Effectiveness of low dose oral minoxidil monotherapy versus low dose oral minoxidil plus low level laser therapy in males with androgentic alopecia - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107700

Enrollment

100

Registered

2026-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Oral minoxidil: Tablet Minoxidil 2.5mg is given orally once daily for 6 months Control Intervention1: LLLT: Low level light therapy is given twice weekly in the first 2 months followed

Eligibility

Inclusion criteria

Inclusion criteria: Male subjects above 18 years of age with AGA of grade 2 to 5 according to modified Norwood - Hamilton scale.

Exclusion criteria

Exclusion criteria: Male subjects below the age of 18 years. Subjects allergic to minoxidil.Subjects on antihypertensives or have any history of cardiovascular diseases/liver diseases/renal diseases.

Design outcomes

Primary

Measure	Time frame
This study will give information on if adding low level light therapy along with oral minoxidil is beneficial or notTimepoint: At baseline and 6 months	—

Secondary

Measure	Time frame
study will add value to the effectiveness of the combination therapy of low dose oral minoxidil and LLLT in patients with AGA. Thus, helping in better management of AGA.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactSubhashini konala

GSL MEDICAL COLLEGE AND GENERAL HOSPITAL

subhashini.idoj@gmail.com9985566999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026